Power Law company profile

Revance Therapeutics

Biotech & Life Sciences · Nashville, United States · Founded 2002 · IPO 2014 Unicorn

Developing neuromodulators for the treatment of aesthetic and therapeutic conditions

Valuation

$643M

Market cap · 2026

Revenue

$234M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

8 investors on Revance Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 8 investors entered at this stage

Bausch Health Companies

Vivo Capital

NovaQuest Capital Management

Essex Woodlands Health Ventures

Palo Alto Investors

EW Healthcare Partners

Technology Partners

Shepherd Ventures

Global footprint

Where Revance Therapeutics has talent and traffic

AI talent share

0.7% of workforce is AI talent
(5 of 728 staff)

Core AI00%

Other AI50.69%

Non-AI workforce72399.31%

Workforce by country

12 countries with
team presence

🇺🇸 United States97%

🇩🇪 Germany0.7%

🇬🇧 United Kingdom0.6%

🇺🇾 Uruguay0.4%

🇨🇦 Canada0.3%

Top 5 of 12 shown

Web traffic by country

38K monthly visits
across markets

🇺🇸 United States77.4%

🇮🇳 India7.9%

🏳️ Korea4.5%

🏳️ Republic of3.2%

🇬🇧 United Kingdom2.6%

Top 5 markets shown

Patent intelligence

$41M patent portfolio · 28 active families

Estimated portfolio value

$41M

6.4% of market cap · 48.9× smaller than top peer Ablynx ($2B)

28 active patent families

Where Revance Therapeutics innovates Botulinum toxinPharmacologyToxinMedicineBotulinum toxin a

Where Revance Therapeutics concentrates vs peers

Each axis is a top-10 topic across Revance Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Revance Therapeutics

An AI-synthesized read of the highest-engagement posts about Revance Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Revance Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles